The 13D Report
The 13D Report
Shareholder activism
⌘K
Signup free
paid-only post activistcompany

Hudson Executive Capital reduced its stake following the resignation of its representative from the Board of Eagle Pharmaceuticals (EGRX)

This post is for paying subscribers only

Subscribe to continue reading


More like this

EHS Announces Three Highly Qualified Director Nominees for Election to TrueBlue (TBI) Board

More Provident Reaches Board Agreement, Withdraws Proxy Contest at ZIM Integrated Shipping Services Ltd (ZIM)

Galloway Capital urges value unlock and stronger IR at Chicago Rivet & Machine Co (CVR)

VA Partners exits Enviva Partners (EVA)

VA Partners secured a Board seat in Insight Enterprises (NSIT)

VA Partners secured a Board seat in LKQ Corp (LKQ)